8-K: Actelis Secures $30M Equity Line, $850K Private Placement

Sentiment:

Capital Raising Agreement


Actelis Networks, Inc. has entered into a $30 million equity line of credit and completed an $850,000 private placement with White Lion Capital LLC to bolster its financial position.

Delay expectedThe Company will incur liquidated damages if it fails to call a special shareholder meeting for Exchange Cap approval within 120 days of October 1, 2025.If the resale registration statement is not declared effective by October 31, 2025 (or November 15, 2025, if reviewed by the SEC), the Company must issue additional shares to White Lion Capital LLC, initially valued at $250,000, and then $250,000 worth of shares for every subsequent 30-day period of delay.If shareholder approval for the Exchange Cap is not obtained by the first required meeting date, the Company is obligated to hold additional special meetings every 90 days for a total period of 360 days until approval is secured.
Capital raise**Equity Line of Credit (ELOC)**: The Company has secured access to up to $30,000,000 in capital through a common stock purchase agreement with White Lion Capital LLC. The Company has the right, but not the obligation, to sell shares to White Lion Capital LLC over a 36-month period, with pricing based on a discount to prevailing market prices.**Private Placement (PIPE)**: The Company completed a private placement with White Lion Capital LLC, raising approximately $850,000. This involved the issuance of 871,766 common shares and pre-funded warrants to purchase up to 3,128,234 additional common shares.

Summary

  • Actelis Networks, Inc. (the Company) entered into a Common Stock Purchase Agreement (Equity Line of Credit ELOC) with White Lion Capital LLC, effective October 1, 2025, granting the Company the right, but not the obligation, to sell up to $30,000,000 in common stock over a 36-month period.
  • Concurrently, the Company completed a private placement (PIPE) with White Lion Capital LLC on September 29, 2025, raising approximately $850,000 in gross proceeds.
  • The PIPE involved the issuance of 871,766 shares of common stock and pre-funded warrants to purchase up to 3,128,234 additional shares, priced at $0.2125 per common share and $0.2124 per pre-funded warrant.
  • The Company retains the right to redeem 488,263 of the shares issued in the PIPE at a price of $0.0001 per share.
  • Both the ELOC and PIPE are subject to an 'Exchange Cap' of 19.99% of the Company's outstanding common stock as of October 1, 2025, requiring shareholder approval for any issuances exceeding this limit.
  • The Company is obligated to file a resale registration statement for all shares issued under both agreements within 5 business days of October 1, 2025, and to seek shareholder approval for exceeding the Exchange Cap within 120 days of the ELOC's effective date.

Sentiment

Score: 6

Explanation: The agreements provide crucial access to capital for a small-cap company, which is a positive for liquidity and operational runway. However, the terms involve significant potential dilution and financial penalties for non-compliance with various deadlines and listing requirements, introducing considerable risk and potential negative impact on existing shareholders. The immediate capital infusion is beneficial, but the long-term cost and potential for market overhang are notable.

Positives

  • Secured access to up to $30,000,000 in capital through the Equity Line of Credit, providing significant financial flexibility for future operations and growth.
  • Successfully completed an $850,000 private placement, immediately strengthening the Company's working capital position.
  • The ELOC structure provides the Company with the discretion to draw funds as needed, offering flexibility in managing its capital requirements without a fixed obligation.
  • The pre-funded warrants issued in the private placement are immediately exercisable at a nominal price of $0.0001 per share and do not expire, providing long-term potential capital.

Negatives

  • Potential for significant shareholder dilution from the issuance of up to $30,000,000 in common stock under the ELOC and the shares/warrants from the $850,000 private placement.
  • The Company faces penalties, including increased commitment fees and additional share issuances, if it fails to maintain its Nasdaq listing, obtain timely shareholder approval for the Exchange Cap, or ensure the resale registration statement is effective by specified deadlines.
  • The pricing mechanism for ELOC shares is tied to market prices (VWAP or lowest traded price), which could result in sales at depressed valuations during periods of stock price decline, exacerbating dilution.
  • A commitment fee of $750,000 (potentially increasing to $1,000,000, $1,250,000, or $1,500,000 if delisted) is payable in shares, representing immediate dilution to existing shareholders.

Risks

  • **Shareholder Dilution**: Future issuances under the Equity Line of Credit and the exercise of pre-funded warrants will dilute the ownership percentage of existing shareholders.
  • **Failure to Obtain Shareholder Approval**: Inability to obtain shareholder approval for issuing shares beyond the 19.99% Exchange Cap could limit the Company's access to the full $30,000,000 ELOC and trigger liquidated damages.
  • **Delisting from Nasdaq**: Failure to maintain the Company's Nasdaq Capital Market listing could trigger increased commitment fees under the ELOC, ranging from $1,000,000 to $1,500,000, and potentially impact market access.
  • **Registration Statement Delays**: Failure to file or have the resale registration statement declared effective by the initial deadline of October 31, 2025 (or November 15, 2025, if reviewed by the SEC) will result in significant share issuance penalties to White Lion Capital LLC ($250,000 worth of shares initially, and every 30 days thereafter).
  • **Market Price Volatility**: The pricing mechanism for ELOC shares, based on market prices, exposes the Company to selling shares at potentially unfavorable valuations during periods of stock price decline, which could accelerate dilution.

Future Outlook

The Company intends to use the net proceeds from the private placement for working capital and general corporate purposes. It plans to obtain shareholder approval for issuing shares beyond the 19.99% Exchange Cap for both the Equity Line of Credit and Private Placement agreements concurrently. The Company is committed to maintaining its Nasdaq Capital Market listing and ensuring the timely filing and effectiveness of the required resale registration statements.

Management Comments

  • The Company's decision to enter into these agreements was based on an independent evaluation by the Company and its representatives.

Industry Context

Small-cap technology companies frequently utilize equity lines of credit and private placements as flexible mechanisms to access capital for operational needs, research and development, or strategic initiatives. These financing instruments are particularly common when traditional debt financing or larger, underwritten public offerings may not be readily available or cost-effective. While providing crucial liquidity, such arrangements typically involve significant potential for shareholder dilution and often include stringent compliance requirements and penalties, reflecting the risk profile and funding dynamics prevalent in this market segment.

Comparison to Industry Standards

  • The 19.99% 'Exchange Cap' without prior shareholder approval is a standard provision in such financing agreements, aligning with Nasdaq rules designed to protect existing shareholders from excessive dilution without their consent.
  • The pricing mechanisms, including discounts to VWAP or lowest traded prices for ELOC shares and a fixed discount for PIPE shares, are typical for 'at-the-market' and private placement transactions, reflecting the liquidity premium provided to the investor.
  • Contractual penalties for delays in registration statement effectiveness and failure to obtain shareholder approval are common investor protections in PIPE and ELOC deals, ensuring the marketability of the investor's securities.
  • The beneficial ownership limitation (4.99%, adjustable to 9.99%) is a standard clause to prevent the investor from inadvertently triggering Section 13D filing requirements or being deemed an 'affiliate' for regulatory purposes without explicit intent.

Stakeholder Impact

  • **Shareholders**: Existing shareholders face potential significant dilution from future stock issuances under the ELOC and the exercise of warrants. There is also a risk of share price volatility due to market sales by White Lion Capital LLC.
  • **Company (Management/Operations)**: The agreements provide essential access to capital for working capital and general corporate purposes, supporting ongoing operations and strategic initiatives. However, they impose strict compliance requirements and potential financial penalties for non-adherence to deadlines and listing standards.

Next Steps

  • File a resale registration statement with the SEC within 5 business days of October 1, 2025, to register shares issued under both agreements.
  • Seek shareholder approval for issuing shares beyond the 19.99% Exchange Cap within 120 days of October 1, 2025, by calling a special meeting.
  • Maintain the Company's listing on the Nasdaq Capital Market to avoid increased commitment fees and potential market access issues.
  • Issue Commitment Shares to White Lion Capital LLC within 30 business days following the effectiveness of the Registration Statement.

Key Dates

DateDescription
2025-09-26Execution Date of the Registration Rights Agreement and the Prefunded Warrant.
2025-09-27Signing Date of the Common Stock Purchase Agreement (ELOC) and the Securities Purchase Agreement (PIPE). Also the Date of earliest event reported on Form 8-K.
2025-09-29Closing Date of the Private Placement (PIPE).
2025-10-01Effective Date of the Common Stock Purchase Agreement (ELOC).
2025-10-06Approximate deadline for filing the Resale Registration Statement for ELOC shares (5 business days after Effective Date).
2025-10-31Initial Required Registration Date for the Resale Registration Statement to be declared effective.
2025-11-15Extended Required Registration Date for the Resale Registration Statement if the SEC notifies the Company of a review.
2026-01-29Approximate deadline for calling a Special Meeting of shareholders to obtain approval for issuing shares beyond the Exchange Cap (120 days after ELOC Effective Date).

Recommendation

hold

The capital infusion from the Equity Line of Credit and Private Placement provides essential liquidity and operational runway for Actelis Networks, which is a positive for a company in its growth stage. However, the potential for substantial dilution from future stock issuances under the ELOC, coupled with the fixed discount pricing and penalties for non-compliance, introduces considerable downside risk for existing shareholders. The stock's future performance will heavily depend on the Company's ability to effectively utilize this capital for growth and achieve operational milestones, outweighing the dilutive effects. Given the immediate capital access balanced against the significant dilution risk and compliance obligations, a 'hold' recommendation is appropriate for seasoned investors to observe execution and market reaction.

Keywords

Actelis Networks, ASNS, Equity Line of Credit, ELOC, Private Placement, PIPE, White Lion Capital, Capital Raise, Share Dilution, SEC Filing, 8-K, Nasdaq, Warrants, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.